Josh Long

The Center for Food Safety agrees with Robert F. Kennedy Jr.’s calls for reform of the industrial food system but expressed caution regarding his ability to enact change under the second Trump administration. Some in the dietary supplement industry are optimistic about Trump’s pick for Kennedy to lead HHS, while others in the sector expressed a commitment to collaborating with top government officials.

Hi, Spring fans! Happy Thanksgiving to my American listeners! and happy Thursday to the everyone! In today's episode I talk to PostgreSQL and PostgreSQL JDBC contributor Dave Cramer. #postgresql #jdbc #sql #java

The brown trout of Lake Ontario deserve the same attention and interest that salmon and steelhead garner from both fly and centerpin anglers.

A clinical-stage pharmaceutical firm wants to intervene in a lawsuit regarding the legality of an anti-aging ingredient marketed in dietary supplement products, but the trade association that filed the complaint against the U.S. Food and Drug Administration opposes the request.

At a trade show in Denver, some industry professionals discussed the burgeoning market for 7-hydroxymitragynine (7-OH), a kratom alkaloid marketed as a potential opioid alternative. Some expressed concerns over its safety and long-term effects, while a representative of a 7-OH brand described the kratom alkaloid as a better mouse trap.”

A medical doctor from the Lone Star State supports restrictions on minors’ access to dietary supplements marketed for weight loss and muscle building.

Another bill targeting dietary supplement products has been pre-filed in Virginia, but HB 1585 faces a limited legislative timeline.

My quest to uncover active criminal cases by asking FDA for the information has yielded no responsive records, and plenty of frustration on my part. I asked legal experts what to do about it.

A lawsuit against the government and amended citizen petition filed with the U.S. Food and Drug Administration by the Natural Products Association could determine the future of β-NMN in dietary supplements, with potentially larger implications for innovation in a $67 billion-a-year industry.

Hi, Spring fans! In this installment I talk to the good and the great Dr. Dave Syer about the (experimental!) new Spring gRPC project!